drugset / Trial / NCT04593511
to Evaluate the Safety, Tolerability and Pharmacokinetics of Four Formulations of LY03009 in Healthy Volunteers
RandomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to Evaluate the Safety, Tolerability and Pharmacokinetics of Four Formulations of LY03009 in Healthy Volunteers.
Timeline
- Start
- 2021-02-02
- Primary completion
- 2021-10
- Completion
- 2021-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY03009 | Unknown | 112 mg | Intramuscular |
| Subject | LY03009 | Unknown | 224 mg | Intramuscular |